INTRODUCTION
The accurate diagnosis of focal liver lesions (FLLs) is important in oncological patients for an accurate staging and in patients without known oncological patholog y for avoiding unnecessary liver biopsies. The widespread use of imaging techniques, such as ultrasound (US), computed-tomography (CT) and magnetic resonance imaging (MRI) has led to a constantly increasing detection and diagnosis of FLLs in completely asymptomatic patients [1] [2] [3] [4] . The frequency of incidentally detected FLLs varies in the literature between 7.2% and 33% for CT, 10.2% and 34.5% for MRI, and between 2.3% and 6.2% for screening US [5] .
Imaging is an important decision-making tool in the diagnosis of FLLs as it can accurately differentiate benign from malignant lesions in most of the cases. The majority of FLLs have a characteristic imaging aspect allowing a confident final diagnosis. In atypical FLLs, follow-up and/or biopsy might be required. In this kind of FLLs, the usage of an J Gastrointestin Liver Dis, September 2015 Vol. 24 No 3: 309-317 additional imaging tool to differentiate benign from malignant lesions would be helpful. It is worth noting that a fortuitously discovered FLL in a patient without known oncological pathology has over a 95% chance of being benign [3] .
Ultrasound has a high sensitivity (Se) for FLLs detection but a low specificity (Sp) for discriminating between different entities (30-60%) [6] [7] [8] . By means of contrastenhanced ultrasound (CEUS), the Sp for benign-malignant differentiation and the final diagnosis of a FLL has significantly increased [9] [10] [11] . The accuracy of CEUS for the final diagnosis of FLL is similar to that of contrast-enhanced CT (90.3% CEUS vs. 87.8% for contrast-enhanced CT) [11, 12] and of contrastenhanced MRI [11, 13] .
CT is recommended in patients with known malignancy for staging, and in patients with chronic liver disease or even in otherwise healthy persons for confirmation of a suspected liver tumor detected on US [14] . The limits of CT are represented by small hypovascular FLLs, such as small metastases, difficult to differentiate from simple liver cysts or from small hemangiomas.
MRI is considered the imaging technique with the best Se and Sp for FLL diagnosis [15] . When compared to US and CT, MRI has a better Se and Sp for the diagnosis of hepatocellular carcinoma (HCC); the detection of HCC in the cirrhotic liver is better by means of MRI (72%) as compared to both CT (65%) and US (48%) examinations [16] . For liver metastases, the detection rate of contrast-enhanced imaging techniques (CEUS, CT, and MRI) has offered comparable results [2] .
Diffusion weighted imaging (DWI) is a relatively recent non-contrast imaging tool. It has a high contrast resolution allowing accurate FLLs detection and characterization [4] . Its principle is based upon measuring the random motion of water into a voxel of tissue. It provides quantitative information about tissue cellularity, depicting between normal parenchyma and malignant tissues [17] . A recent application of MRI and of DWI in particular, the apparent diffusion coefficient (ADC) value is a measure of the magnitude of diffusion within a tissue. The ADC values are automatically calculated by software and displayed as a parametric map. The ADC measurements are possible for a given region by drawing the regions of interest (ROI) on the ADC map [19, 20] . Usually, malignant FLLs are characterized by a restricted diffusion defined by hyperintensity on the b-800 image and hypointensity on the ADC map. Benign FLLs with fluid content (such as hemangioma or biliary cysts) are characterized by hyperintensity both on the DWI at high b-values, and on the ADC map, behavior known as "T2-shine through" [4] . DWI is an excellent method for the detection and the differential diagnoses of liver metastasis (Se 87% and Sp 97%) compared with triphasic CT (Se 53% and Sp 78%) [18] .
The aim of this study was to assess the role of DWI, routinely used in hepatic MRI for the differentiation of FLLs as benign or malignant.
MATERIAL AND METHODS

Patients
One hundred and thirty consecutive liver MRI examinations realized between June 2013 and May 2014 were retrospectively analyzed and a total number of 225 FLLs were detected.
The patients had different pathologies: hepatic nodules in a cirrhotic liver, malignancy elsewhere in the body, accidentally discovered FLLS on MRI or US.
Inclusion criteria: the presence of at least one FLL with a histological analysis or consensus MRI reading by two experienced radiologists and a six months follow-up scan, confirming that the lesion has the same aspect and the same size.
Exclusion criteria: the patients without histological proof and without a typical aspect on MRI as defined above (12 patients with 17 FLLs). Also excluded were patients with DWI sequence not done or non-interpretable DWI sequences due to artifacts (18 patients with 27 FLLs). Also, 68 cystic FLLs (most of them simple cysts), lesions smaller than 1 cm (9 FLLs) and FLLs located in the upper left liver lobe (potential artifacts given by the proximity of the heart: 3 FLLs) were excluded (i.e., a total number of 18 patients). Two more patients were excluded because they were outliers -very low ADC value, due to the rich iron content (benign regenerative nodules in cirrhotic livers).
MRI
Protocol
All liver MRI examinations were done using the same machine (Siemens, 1,5T, Erlangen, Germany) and the ADC values were calculated based on three b-values (b-50, b-400 and b-800). A routine MRI protocol was used: T2-haste in coronal and axial planes, TIRM and T1-in and out of phase in axial plane, T2-Trufi in the axial and coronal planes, DWI and ADC map, T1 vibe before and after the injection on contrast media. After injection of contrast media, the liver was scanned in the arterial, portal and late phases; in some examinations, the liver specific contrast media-Gd-EOB-DTPA-(Primovist, Bayer-Shering Pharma, Berlin, Germany) was used: for these cases, a hepatobiliary phase was also obtained.
Image analysis
The following data were recorded for each patient: sex, age, size of the lesion, histologic diagnosis of the assessed FLL. The MRI images were read by two independent readers, experienced radiologists, blinded to each other's results and to the histological diagnosis. They assessed independently the FLLs aspect on DWI at b-800 and on the ADC map, the ADC value and the ADC ratio as described above. A 5-level scale was used to assess the signal at b-800 with 1 meaning hypointensity and 5 strong hyperintensity and a 3-level scale to assess the ADC aspect with 1-hypointensity, 2-isointensity to the liver parenchyma and 3-hyperintensity.
The ADC value of each FLL was calculated within a region of interest (ROI) placed in the center of the assessed FLL, covering more than 50% of its surface. In cases of necrotic FLLs (metastases or HCC), measurements were taken only in the solid part, trying to avoid inclusion within the ROI of any necrotic part. In order to avoid variations of the ADC value in the surrounding liver, measurements were taken approximately at the level of the assessed FLL. The ADC ratio was calculated using the obtained ADC values, the one for the assessed FLL, and the other one for the surrounding liver parenchyma.
For patients with multiple FLLs, each lesion was individually analyzed. 
Statistical analysis
The data were first descriptively analyzed. As the normality of the distribution was accepted, the t test (Student) was applied either in the Independent Samples (benign vs. malignant), or in the Paired Samples version (inter-observer variability), depending on the features assessed. For ordinal data, comparisons were made using the Spearman correlation coefficient, while for scale data the Pearson coefficient was employed. In the case of ordinal data, comparisons between the two types of FLLs were made, based on nonparametric tests -the median. When qualitative data were analyzed, the Chi-square test, along with the contingency and the uncertainty coefficients were applied (with group proportion comparisons and adjusted p-value -Bonferroni method).
In order to assess the predictability power of the analyzed measures, the ROC curve was constructed and its parameters were estimated: Se, Sp, positive predictive value (PPV), and NPV (negative predictive value).
In all cases, the standard significance level of 5% was used as a starting point (Sig. = p-value < 0.05). However, due to effective values obtained, confidence level was either augmented at 99%, or diminished at 90%.
RESULTS
Patients' characteristics A total number of 80 patients were finally included in the study: 42 men (52.5%) and 38 women (47.5%). The average age of the patients was of 59.84 ± 11.48 (age range: 21-81 years), being significantly lower (p = 0.038) in women (57.05 ± 12.20) than in men (62.36 ± 10.29).
Analyzed focal liver lesions
A total number of 99 FLLs were finally included in the study, an average of 1.237 FLLs/patient. The number of malignant FLLs in women (23) was significantly lower than that in men (33) (p = 0.025).
The distribution of the 99 analyzed FLLs was: 39 hemangiomas, 4 focal nodular hyperplasias (FNHs), 26 hepatocellular carcinomas (HCCs), 23 liver metastases, and 7 cholangiocarcinomas (CCCs).
The mean size of the assessed FLLs was 32.32 ± 2.01 mm . The mean size of the benign FLLs was 24.07 ± 17.06 mm and of the malignant FLLs 38.67 ± 28.2 5mm.
Signal qualitative analysis on the b-800 DWI and on the ADC map
The statistical analysis of the qualitative assessment of signal intensity on the b-800 showed a p value of 0.695 (not significant) proving an important overlap in signal intensities of benign and malignant FLLs. Results are summarized in Table I .
The qualitative analysis of signal intensity on the ADC map showed that these parameters can be confidently used in order to diagnose malignant FLLs when they are hypointense on the ADC map. A lesion with lower ADC value than the ADC value measured in the surrounding liver parenchyma is 100% malignant as our results have proved. The Sp of hyperintensity on the ADC map for benign FLLs was 92.1% (Table II) . (Fig. 1) . The values of ADC for benign and malignant FLLs, as well as the ADC ratios for benign and malignant FLLs are reflected in Table III . Figure  2 illustrates the ADC-ratio for benign and malignant FLLs.
The ADC values as well as the ADC ratios for benign FLLs proved to be significantly higher than those for malignant FLLs. The mean value of the ADC ratio for malignant FLLs was, for both readers, lower than 1. We can conclude that both the ADC value and the ADC ratio are significantly lower for malignant FLLs, at a confidence level of 99% (p = 0.000). The differences between the ADC value and the ADC ratio for benign and malignant FLLs are shown in Table III .
Inter-observer variability
The study of the inter-observer variability demonstrated a good correlation between the two independent readers. The correlation coefficients showed a very strong link between the variables, which means nearly similar data interpretation by the two readers. Their value are significant at a significance level of 1% (Sig = p-value = 0.000). The value which was less prone to variations between readers was the ADC value (0.919 → 1). The correlation between readers is illustrated in Table  IV . Inter-observer variability was also assessed by using the paired-samples t test. The analysis of the ROC curve offered statistically significant results for the qualitative assessment of the signal on the ADC map, for the ADC value and for the ADC ratio. The area under the curve showed high values for all the three variables: 0.932, 0.951, and 0.967, respectively. The ADC ratio had the best predictive value for discriminating between benign and malignant FLLs. The signal analysis of b-800 sequence alone is not a significant diagnostic factor in the prediction of malignancy (AUROC = 0.454, Sig. = 0.433).
The diagnostic value of the qualitative assessment of lesion signal on the ADC map is important for malignant FLLs. If a FLL could be confidently classified as hyposignal on the ADC map, there was a Se of 55.4% and a Sp of 100% for malignancy. When we included both iso-and hyposignal of a FLL, there was a Se of 94.6% for malignancy at a false positive rate of 18.6%.
For the ADC value/FLL, a threshold of 1024 led to a Se for malignancy of 62.5% and a rate of false-positive results of 0%. Using a higher threshold, such as 1040, the Se for malignancy was 66.1%, at a false-positive rate of 5%. The obtained Se, Sp, NPV, and PPV for the ADC values, ADC ratios and for the lesion aspect on the ADC map are illustrated in Table V .
For the ADC ratio we had a false-positive rate of 0 for a cut-off of 0.9854 (every lesion with a lower ADC ratio than 0.9854 was malignant). The Se for malignancy for this cut-off was 57.1%. If we used a cut-off value of 1.22, the Se was 94.6% for a Sp of 95%. also in patients with severe renal insufficiency [4] . The most used parameter for quantification in DWI for abdomen assessment is the ADC value requiring at least two b-values (a low and a high b value) [21] [22] [23] [24] .
Benign fluid FLLs (hemangiomas and biliary cysts) show hyperintensity on the DWI image and also hyperintensity on the ADC map, the pattern known as "T2 shine through". Benign solid FLLs are not or only slightly distinguishable from the liver parenchyma on the DWI at higher b-value and are iso/slightly hyperintense compared to the surrounding liver on the ADC map. Malignant FLLs, such as HCC nodules or metastases, present a pattern known as "restricted diffusion", i.e. hyperintensity on the DWI image and hypointensity on the ADC map [4] .
Hemangioma is typically strongly hyperintense on a T2-weighted sequence and enhances in a centripetal way (Fig.  3) . The signal intensity of hemangiomas on the ADC map is slightly lower than the signal of biliary cysts [25, 26] .
Focal nodular hyperplasia (FNH) is hypervascular in the arterial phase and does not show wash-out on portal or delayed phases. Also it shows a central scar which is typically hyperintense on T2 weighted images (Fig. 4) . But as the presence of the central scar is an inconstant finding and some malignant lesions can present similar enhancing pattern, e.g. hypervascularity in the arterial phase associated with absence of wash-out in later phases, the use of another diagnostic tool such as DWI can be of great help in differentiating FNHs from malignant FLLs.
Hepatocellular adenomas (HCAs) are infrequent FLLs which in most cases appear in a specifical clinical context: young woman taking oral contraceptives. Hepatocellular adenoma mimics the vascular aspect of FNH.
Previous papers highlighted a significant overlap between the ADC value of benign solid FLLs (such as FNH and HCA) and malignant FLLs [26, 27] . Our series shows a slight difference between the mean ADC values for NFHs (1036), not significantly higher than the mean ADC value for malignant FLLs (953). Our conclusions are limited by the low number of NFHs taken into account (n=4). Regarding HCAs, a recent study sustained that their mean ADC value is significantly higher than that of malignant FLLs [28] . The result needs to be proved by further studies, but additional research is difficult due to the fact that HCAs are rare lesions and obtaining statistically relevant series will be difficult. The meta-analysis by Chen et al. [26] reports no significant differences between ADC values of FNHs and adenomas. There is a possibility that the variations of the ADC values and of the DWI b-800 aspects of liver HCAs are due to different histological subtypes.
Metastases are usually multiple, hypovascular in both arterial and portal phases and have an enhancing peripheral ring, which rapidly washes out. They show restricted diffusion and are hypointense in the hepatobiliary phase after the injection of liver-specific contrast media (Fig. 5 ). Every FLL with arterial hyperenhancement and portal or late phase washout appearing in a cirrhotic liver is considered to be an HCC nodule until proved otherwise [29] (Fig. 6) .
DWI is considered to be more useful in the diagnosis of liver metastases than of HCC because metastases have a lower ADC value: they are clearly in hyposignal as compared to the surrounding liver [30] . The HCC diagnosis is even more difficult because the cirrhotic liver shows restricted diffusion itself making HCC lesions difficult to spot on the ADC map. In our series, the mean ADC values of HCC and of metastases were relatively similar, without significant differences in the behavior of HCCs and metastases on the ADC map. Kim et al. [31] showed that hyperintensity on DWI at b-800 can accurately differentiate HCC from the benign hepatic nodules which are hypoattenuating in the hepatobiliary phase. Parsai et al. [32] reported an increased ADC value for CCCs as compared to other malignant FLLs, but further research is required because the number of CCCs in their study was low (n=4). In our series, the mean ADC value (1080) of CCCs (n=7) was also higher than the mean ADC value of malignant FLLs. Our study proves that the correct qualitative and quantitative analysis of DWI b-800 and ADC maps can improve the differential diagnosis of FLLs differentiating benign from malignant lesions; a lesion with a distinct lower signal on the ADC map than the surrounding liver can be classified as malignant. However, a study by Miller et al. [33] suggests that solid benign FLLs may show restricted diffusion and be hypointense on the ADC map. In our series there were no FNH nodules with either strong hyperintensity on the DWI or with hypointensity on the ADC map. But the small number of FNH nodules included (4) does not allow us to make conclusions about the behavior of FNH nodules on DWI.
The present study shows, in accordance with other published studies, that interpreting the DWI b-800 signal alone is not helpful in differentiating benign from malignant FLLs [4, [21] [22] [23] [24] 34] . The quantitative assessment of the ADC value and the ADC ratio has better diagnostic value than the qualitative evaluation of restricted diffusion, i.e. hyperintensity of the FLL on b-800 and hypointensity on the ADC map.
Mean ADC values of the liver and ADC thresholds used in order to separate benign from malignant FLLs vary largely in different papers [22, [34] [35] [36] [37] . The great variability in calculating ADC values is due to different acquisition schemes of MRI machines, gradient performances and artifacts reduction methods [21] . In order to avoid these variations we introduced the ADC ratio. The ADC ratio is not so prone to variations related to the machine used or to acquisition technique. The AUROC proves that the ADC ratio has the best predictive power for discriminating between malignant and benign FLLs. As far as we know, our paper is the first to use the ADC ratio for discriminating between benign and malignant lesions in liver pathology. Previously, the ADC ratio was proved to be a good diagnostic tool for malignancy in prostatic cancers [38] . On the other hand, the ADC value is less prone to variations between readers. The ADC ratio might be a better and more objective discriminator between benign and malignant FLLs but this has to be proved by further research.
By comparing our data with the literature (Table VI) , differences in Se and Sp are small and mostly due to the usage of different MRI machines, different imaging techniques, and also different b-values used in clinical practice.
The only study with significantly different results from ours is that of Gourtsoyianni et al. [35] . In their series of 39 patients with 37 FLLs the benign lesions were mainly biliary cysts (15 out of 22 FLL) with significantly higher ADC than any other FLL.
Our study has as limitation the retrospective analysis and the fact that not all of the included patients had a histological analysis of the assessed FLL. However, as the vast majority of hemangiomas do not require biopsy for a correct diagnosis, by restricting the FLLs included in the study to lesions confirmed by histology, we would virtually exclude hemangiomas from the study. Also, we excluded from the study iron containing FLLs (regenerative nodules) because of their very low ADC value which would have biased our data.
CONCLUSIONS
The ADC value, the ratio between the ADC value of the lesion and the ADC value of the surrounding liver parenchyma have very good accuracy in differentiating benign from malignant FLLs. Quantitative methods (such as ADC value and ADC ratio) offer better diagnostic accuracy than the qualitative appreciation of signal intensity on the DWI b-800 and on the ADC map. Nevertheless, a FLL clearly hypointense as compared to the surrounding liver on the ADC map is almost certain to be malignant. The ADC ratio has a better sensitivity and specificity for the diagnosis of malignant FLLs than the ADC value.
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